Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN PHARMACEUTICALS vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUVEN PHARMACEUTICALS   ADCOCK INGRAM
EQUITY SHARE DATA
    SUVEN PHARMACEUTICALS
Mar-23
ADCOCK INGRAM
Jun-14
SUVEN PHARMACEUTICALS/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs629314-   
Low Rs388226-   
Sales per share (Unadj.) Rs52.793.4-  
Earnings per share (Unadj.) Rs16.2-23.5-  
Cash flow per share (Unadj.) Rs18.0-19.5-  
Dividends per share (Unadj.) Rs6.000-  
Avg Dividend yield %1.20-  
Book value per share (Unadj.) Rs68.273.3-  
Shares outstanding (eoy) m254.57168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x9.72.9 333.7%   
Avg P/E ratio x31.5-11.5 -274.0%  
P/CF ratio (eoy) x28.2-13.9 -203.4%  
Price / Book Value ratio x7.53.7 202.3%  
Dividend payout %37.10-   
Avg Mkt Cap Rs m129,39545,603 283.7%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m1,1052,862 38.6%   
Avg. sales/employee Rs Th03,671.4-  
Avg. wages/employee Rs Th0666.7-  
Avg. net profit/employee Rs Th0-925.1-  
INCOME DATA
Net Sales Rs m13,40315,761 85.0%  
Other income Rs m464110 420.1%   
Total revenues Rs m13,86715,872 87.4%   
Gross profit Rs m5,739-2,731 -210.1%  
Depreciation Rs m477680 70.2%   
Interest Rs m128427 30.0%   
Profit before tax Rs m5,597-3,728 -150.1%   
Minority Interest Rs m0-10 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,484233 637.2%   
Profit after tax Rs m4,113-3,971 -103.6%  
Gross profit margin %42.8-17.3 -247.1%  
Effective tax rate %26.5-6.2 -424.4%   
Net profit margin %30.7-25.2 -121.8%  
BALANCE SHEET DATA
Current assets Rs m11,55411,544 100.1%   
Current liabilities Rs m3,0316,495 46.7%   
Net working cap to sales %63.632.0 198.5%  
Current ratio x3.81.8 214.5%  
Inventory Days Days148111 133.9%  
Debtors Days Days302124 243.8%  
Net fixed assets Rs m9,5476,729 141.9%   
Share capital Rs m25573 347.9%   
"Free" reserves Rs m17,0970-   
Net worth Rs m17,35212,371 140.3%   
Long term debt Rs m464,347 1.0%   
Total assets Rs m21,10123,369 90.3%  
Interest coverage x44.7-7.7 -578.0%   
Debt to equity ratio x00.4 0.7%  
Sales to assets ratio x0.60.7 94.2%   
Return on assets %20.1-15.2 -132.5%  
Return on equity %23.7-32.1 -73.8%  
Return on capital %32.9-19.8 -166.1%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m12,8240-   
CASH FLOW
From Operations Rs m4,5091,345 335.2%  
From Investments Rs m-1,948-413 471.7%  
From Financial Activity Rs m-2,3583,945 -59.8%  
Net Cashflow Rs m2024,878 4.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.33 Rs / ZAR

Compare SUVEN PHARMACEUTICALS With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare SUVEN PHARMACEUTICALS With: ISHITA DRUGS  CONCORD DRUGS  AMI ORGANICS  FREDUN PHARMA  LYKA LABS  



Today's Market

Sensex Today Trades Flat | Nifty Below 22,350 | Kotak Mahindra Bank Tanks 9% Sensex Today Trades Flat | Nifty Below 22,350 | Kotak Mahindra Bank Tanks 9%(10:30 am)

Asian stocks fell on Thursday as disappointing earnings forecasts from Facebook parent Meta Platforms hammered tech shares, while the yen's slump past 155 per dollar.